There is considerable evidence from several imaging cardiometabolic studies that excess visceral adipose tissue accumulation is associated with a constellation of cardiometabolic abnormalities for which hypertriglyceridemia is a key feature. This satellite symposium will provide an update on visceral obesity as a clinical entity requiring new tools for clinical assessment and management. It will also provide evidence that the hypertriglyceridemia of visceral obesity is particularly atherogenic as it reflects atherogenic dysfunctions in subcutaneous adipose tissue and lipoprotein metabolism, leading to the formation of atherogenic remnants. Therapeutic and preventive options will also be reviewed.
This IAS/ICCR joint satellite symposium is supported by an unrestricted grant from Kowa Company, Ltd.
Date: Wednesday, June 13, 2018
Time: 08:30 – 17:30
Location: Room 717, Metro Toronto Convention Centre (MTCC)
CLICK HERE TO REGISTER